The Impact of an Adaptive Patient-centered Web Application on Medication Optimization in HFrEF Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 225 participants.

Also called NCT05858320

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 225 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05858320
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05858320. Randomized; single masking; primary purpose treatment. Start 2023-07-21 (actual); primary completion 2025-12-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Impact of an Adaptive Patient-centered Web Application on Medication Optimization in HFrEF Patients
Acronym
SmartHF
Condition
Heart Failure
Intervention (Other)
SmartHF application
Lead sponsor
University of Michigan (class: other)
Collaborator
Washington University, Barns Jewish Hospital, St. Louis, MO (class: not stated)
Collaborator
Henry Ford Hospital, Detroit, MI (class: not stated)
Collaborator
Emory University, Grady Hospital, Atlanta, GA (class: not stated)

Record details

Record id
cardio:ct-nct05858320
Content hash
d01a84c97d0ab37ab552682f609812918ed0b9513358d1ee1baf08396a357326